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Abstract: Age-related hearing impairment (ARHI) is a progressive and a common sensory 
disorder in the elderly and will become an increasingly important clinical problem given the 
growing elderly population. Apoptosis of cochlear cells is an important factor in animal models 
of ARHI. As these cells cannot regenerate, their loss leads to irreversible hearing impairment. 
Identification of molecular mechanisms can facilitate disease prevention and effective treat-
ment. In this study, we compared the expression of the genes BAK1 and BCL2 as two arms of 
the intrinsic apoptosis pathway between patients with ARHI and healthy subjects. ARHI and 
healthy subjects were selected after an ear nose throat examination, otoscopic investigation, 
and pure tone audiometry. RNA was extracted from peripheral blood samples, and relative gene 
expression levels were measured using quantitative real-time polymerase chain reaction. BAK1 
and the BAK1/BCL2 ratio were statistically significantly upregulated in the ARHI subjects. The 
BAK1/BCL2 ratio was positively correlated with the results of the audiometric tests. Our results 
indicate that BAK-mediated apoptosis may be a core mechanism in the progression of ARHI in 
humans, similar to finding in animal models. Moreover, the gene expression changes in peripheral 
blood samples could be used as a rapid and simple biomarker for early detection of ARHI.
Keywords: age-related hearing impairment (ARHI), presbycusis, biomarker, treatment
Introduction
Age-related hearing impairment (ARHI), or presbycusis, is the most common 
multifactorial sensory disease in the elderly.1 ARHI has a huge societal impact as a 
result of its effects on quality of life and is a public health concern.2 It is a bilateral, 
symmetrical, and sensorineural high-frequency impairment. Damage or loss of the 
inner ear hair cells and spiral ganglion cells is an important cause of ARHI,3 and a 
study on the auditory organ of aging mice demonstrated that apoptosis is a major form 
of cell death.4 As these cells are not able to regenerate, their loss causes irreversible 
hearing impairment.
There are two pathways for cell signal transmission in apoptosis: intrinsic and 
extrinsic. The BCL-2 protein family is responsible for the intrinsic pathway. Genes 
of this family are divided into two categories that include proapoptotic genes (BAK1, 
BAX, BAD) and antiapoptotic genes (BCL2, BCLXL).5 An investigation of early-onset 
hearing loss (HL) in a mouse model demonstrated upregulation of the apoptosis-
related genes Bak1 and Casp3 during the development of ARHI.6 In addition, the 
MCAT transgenic mice exhibit delayed onset of age-related HL, and investigation of 
the underlying molecular mechanisms revealed a decreased in the mRNA expression 
level of Bak1 in the cochlea and a reduction in cell death.7 Moreover, C57BL/6J mice 
Correspondence: Mohammad Farhadi
enT and head & neck research Center 
and Department, Iran University of 
Medical sciences, niayesh st, sattarkhan 
Ave, Tehran, Iran
Tel +98 912 422 4834
Fax +98 21 6652 5329
email mfa.ent@gmail.com
Mohammad Najafi
Cellular and Molecular research Center, 
Biochemistry Department, Iran University 
of Medical sciences, shahid hemmat 
highway, Tehran, 1449614535, Iran
email nbsmmsbn@iums.ac.ir 
Journal name: Clinical Interventions in Aging
Article Designation: Original Research
Year: 2016
Volume: 11
Running head verso: Falah et al
Running head recto: Expressions of the BAK1 and BCL2 genes for the diagnosis of ARHI
DOI: http://dx.doi.org/10.2147/CIA.S109110
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
22
5.
18
7.
18
0 
on
 1
6-
O
ct
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Interventions in Aging 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1004
Falah et al
with a deletion of the Bak1 gene exhibited a reduction in 
age-related apoptotic cell death of hair cells in the cochlea 
and spiral ganglion neurons, resulting in the postponement 
of ARHI.7
High expression of Bcl2 and Bcl-xL was identified as a key 
factor in inner ear aging in the mouse cochlea by Tadros et al.8 
Given the role of apoptosis in ARHI, Yang et al6 reported an 
antiapoptotic treatment that resulted in the preservation of 
hearing and reduced outer hair cell loss at the cochleae of 
DBA/J2 mice. Understanding the mechanism of cell apop-
tosis in ARHI will not only shed light on the intracellular 
mechanisms underlying aging of the cochlear but also make 
it possible to manipulate these mechanisms for treatment and 
prevention of this common human impairment.
The aim of this study was to investigate the role of 
expression of two genes, representing different arms of 
the BCL-2 protein family, BAK1 (proapoptotic) and BCL2 
(antiapoptotic), in peripheral blood samples from ARHI 
patients in comparison to healthy subjects.
Materials and methods
A total of 52 subjects with ARHI and 29 healthy subjects 
were selected by otolaryngologist at the ENT and Head & 
Neck Research Center of Iran University of Medical Science. 
The participants signed informed consent letters prior to 
inclusion in the study. This study was approved by the Ethics 
Committee of Iran University of Medical Sciences.
All subjects completed a questionnaire to determine their 
medical history and environmental factors that may have 
affected their ability to hear. Subjects who had experienced 
factors known to affect hearing sensitivity were excluded 
from the study.9,10 The relevant factors included exposure to 
ototoxic drugs, early-onset hearing impairment, history of 
any known cause of sensorineural HL, external or middle 
ear disease, cognitive dysfunction, neurological or psychi-
atric disease, brain tumor or vestibular schwannoma, liver 
cirrhosis, renal failure, cardiovascular disease, history of 
stroke, and cancer.
Otoscopic examination, tympanometry, pure tone audiom-
etry, and measurement of speech reception thresholds (SRTs) 
and speech discrimination scores (SDSs) were performed for 
all subjects at the Audiology Department. Tympanometry 
was performed using an Amplaid 728 (Amplaid Inc., Milan, 
Italy) multifrequency admittance meter. Pure tone audi-
ometry was performed using an Amplaid 319 audiometer 
(Amplaid Inc.). Calibration was performed according to 
American National Standards Institute standards (ANSI 
S3.6-2004, ANSI, 2004a). Air conduction thresholds were 
measured at 250, 500, 1,000, 2,000, 4,000, and 8,000 Hz, 
and bone conduction thresholds were measured at 500, 1,000, 
2,000, and 4,000 Hz with the same conditions for all subjects. 
SRT was performed by presenting four spondaic words to 
each patient, according to the Farsi-language version of the 
staggered spondaic word test, at different intensities.11 The 
SRT was defined at the lowest intensity that a patient could 
repeat 50% of spondees correctly. SDS was performed by 
presenting 25 unfamiliar one-syllable words at 40 dB above 
the SRT for the patient. The percentage of words which the 
patient understood and repeated correctly was defined as 
the SDS. Audiological exclusion criteria were conductive 
HL (mean air–bone differences at 500, 1,000, and 2,000 Hz 
of more than 15 dB); acoustic trauma (differences between 
air thresholds at 4,000 and 8,000 Hz exceeding 20 dB); or 
experience of extensive noise exposure (self-report).
Subjects with ARHI had symmetric, bilateral hearing 
impairment with pure tone average (PTA) values at medium 
frequencies (1, 2, 4, and 8 kHz) of $30 dB HL. The healthy 
subjects had normal ear examinations and PTA values at 
medium frequencies of ,25 dB HL (Figure 1).
Total RNA samples were extracted from 1 mL of peripheral 
blood using a QIAamp RNA Blood Mini Kit (Cat No 52304; 
QIAGEN, Hilden, Germany), according to the manufacturer’s 
instructions. cDNA was synthesized from 1 μg total RNA 
using a QuantiTect Reverse Transcription Kit (Cat No 205311; 
QIAGEN) according to the manufacturer’s instructions.
Figure 1 Mean air conduction hearing threshold.
Note: error bars represent standard deviations (sDs).
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expressions of the BAK1 and BCL2 genes for the diagnosis of ArhI
Quantitative real-time polymerase chain reaction (qPCR) 
analysis was performed for BAK1, BCL2, and the housekeep-
ing gene ACTB, which was selected as a reference gene. 
qPCR was performed using specific primers (Table 1) and 
RealQ-PCR Master Mix with Green DNA dye (Cat No 
250507; Ampliqon, Odense, Denmark) in a Rotor-Gene6000 
instrument (Corbett life Science, Sydney, Australia). All 
reactions were performed in duplicate in a total volume of 
25 μL, containing 12.5 μL of RealQ-PCR 2× Master Mix, 
0.4 μL of each primer (10 pmol), 1 μL cDNA, and 10.7 μL 
RNase-free water. A two-step PCR program was used, with 
an initial activation step for 15 minutes at 95°C, followed by 
35 cycles of denaturation at 95°C for 20 seconds, and anneal-
ing and extension at 60°C for 60 seconds. The threshold 
cycle (Ct) was determined for BAK1, BCL2, and ACTB in 
each sample. Gene expression levels were calculated using 
the following equation:
 Relative copy number =2−ΔCt (ΔCt = Ct
GENE
 − Ct
ACTB
). 
Statistical analysis was performed using SPSS 22 for 
Windows (IBM Corporation, Armonk, NY, USA). Statis-
tical significance was defined as P,0.05. All numerical 
variables were checked for normal distribution using the 
one-sample Kolmogorov–Smirnov test. The Mann–Whitney 
U-test was used for the comparison of gene expression 
values between ARHI and healthy subjects. The Spear-
man’s rank-order correlation was used to evaluate poten-
tial correlations between PTA, SRT, and SDS, and gene 
expression.
Results
The mean ages of ARHI and healthy subjects were 66.7±9 years 
and 64±6.4 years, respectively. The sex balance was 54.3% 
male and 45.7% female, with no statistically significant differ-
ences in age (t [79] =−1.5; P=0.13) and sex (χ2 [1, N=81] =1.6; 
P=0.2) between ARHI and healthy subjects.
BAK1 and BCL2 gene expression levels were deter-
mined in ARHI and healthy subjects, relative to those of the 
ACTB gene. The difference between the BAK1 expression 
level in ARHI subjects (median =1) compared to healthy 
subjects (median =0.34) was statistically significant (U=484, 
P=0.008); hence, the ARHI subjects exhibited elevated levels 
of expression of the proapoptotic gene, BAK1, compared with 
healthy subjects (Figure 2).
A Mann–Whitney U-test indicated that levels of expres-
sion of the antiapoptotic gene, BCL2, were also greater 
for ARHI (median =1.06) compared with healthy subjects 
(median =0.58; U=548, P=0.04) (Figure 3).
Since the balance between pro- and antiapoptotic mem-
bers of the BCL-2 protein family is a key factor in apoptosis, 
we evaluated the BAK1/BCL2 expression ratio, revealing a 
statistically significant difference between ARHI and healthy 
subjects (U=544, P=0.039). The BAK1/BCL2 median ratios 
for ARHI and healthy subjects were 1.46 and 0.8, respec-
tively (Figure 4).
Next, correlations between the BAK1/BCL2 ratio and 
differences in auditory perception were evaluated. Audi-
tory perception measures included PTA, SRT, and SDS. 
As the data were not normally distributed, we performed 
Spearman’s rank-order correlation analysis. The results 
revealed a significant and positive correlation between 
BAK1/BCL2 ratio and PTA (r
s
[81] =0.3, P=0.015) and SRT 
Table 1 sequences of the PCr primers for BAK1, BCL2, and ACTB
Gene GenBank 
accession number
Amplicon 
size (bp)
Reverse primer Forward primer
BAK1 nM_001188.3 120 CAA ACA ggC Tgg Tgg CAA TC TCA TCg ggg ACg ACA TCA AC
BCL2 nM_000633.2 129 CAg CCA ggA gAA ATC AAA CAg Agg ATC gCC CTg Tgg ATg ACT gAg
ACTB nM_001101.3 131 gTA gTT TCg Tgg ATg CCA CA TCC CTg gAg AAg AgC TAC g
Abbreviation: PCr, polymerase chain reaction.
Figure 2 gene expression of BAK1 in peripheral blood samples from Iranian patients 
with ArhI and healthy subjects.
Notes: The difference between the two groups is statistically significant (U=484, 
P=0.008). The box plots show the median (solid line across the box).
Abbreviation: ArhI, age-related hearing impairment.
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(r
s
[81] =0.3, P=0.007). In addition, there was a significant 
negative correlation between SDS and the BAK1/BCL2 ratio 
(r
s
[81] =0.25, P=0.03).
Discussion
BCL-2 protein family members regulate mitochondrial 
membrane permeabilization during apoptosis, with BAK1 
and BAX proteins forming an apoptotic pore within the mito-
chondrial outer membrane.12 A recent study demonstrated 
that the role of the carboxyl terminus of BAK1 in lining the 
apoptotic pore or aggregating on the membrane surface is 
key to the destabilization of the mitochondrial outer mem-
brane by BAK1 to generate pores and consequent initiation 
of the apoptotic cascade.13 Various different tissues in a 
BAK1-deficient mouse model showed a marked reduction 
in apoptosis,14 and BAK1 played a central role in apoptosis-
mediated murine cerebral cortical neuron degeneration after 
DNA damage.15 Furthermore, C57BL/6J mice with a deletion 
in Bak1 have reduced apoptotic cell death and exhibit a delay 
in onset of ARHI.7 Oxidative stress, an important factor in 
age-related diseases, induces Bak1 expression in primary 
cochlear cells, leading to apoptosis; however, apoptotic cell 
death is prevented in Bak1-deficient mice, even under condi-
tions of oxidative stress.7
This study demonstrated a statistically significant increase 
in the BAK1 gene expression level in ARHI compared to 
healthy subjects (Figure 2). A possible explanation for 
this could be a general increase in apoptosis among ARHI 
subjects. This result is in agreement with that reported by 
Dong et al,16 demonstrating an association between immune- 
and apoptosis-related genes and ARHI.
In this study, we found that BCL2 was significantly upregu-
lated in ARHI subjects (Figure 3). Tadros et al8 reported an 
increase in expression of the apoptosis-related genes, Bcl2 
and Bcl-xL, in the cochlea of the mice with age-related HL. 
They hypothesized that higher expression of Bcl2 in the age-
related HL model, the CBA mouse, may be a protective effect 
induced during the cochlear aging process.8 A previous study 
of the mechanism of BCL-2 family regulation of the onset of 
apoptosis in cells demonstrated that BCL2 inhibits the acti-
vation of BAK1 by binding to this protein in healthy cells.17 
Neomycin, an aminoglycoside antibiotic, induces cell death 
of inner hair cells; however, over expression of Bcl2 prevents 
neomycin-induced HL in adult mice.18 The significantly higher 
expression of BCL2 in our ARHI subjects provides further sup-
port for the role of BCL2 in a defense response mechanism in 
age-related HL in humans after the upregulation of BAK1.
Experimental evidence indicates that the ratio of anti- and 
proapoptotic BCL-2 protein family members is a key factor in 
determining cell death or survival.19,20 The BAK1/BCL2 median 
ratio was significantly elevated in ARHI compared with healthy 
subjects, indicating the potential importance of the role of 
BAK1 gene expression, which may be indicative of increased 
apoptosis among ARHI subjects (Figure 4). These results were 
consistent with data obtained from humans and mouse models, 
demonstrating a reduced neuron size and a decline in the medial 
olivocochlear efferent system during ARHI.21–23
This study demonstrated positive correlations between 
the BAK1/BCL2 ratio and PTA and SRT values. Hence, our 
results indicate an association between gene expression levels 
related to elevated apoptosis and increased PTA and SRT 
Figure 3 gene expression of BCL2 in peripheral blood samples from Iranian patients 
with ArhI and healthy subjects.
Notes: Difference between the two groups is statistically significant (U=548, P=0.04).
Abbreviation: ArhI, age-related hearing impairment.
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Figure 4 The BAK1/BCL2 gene expression ratios of Iranian patients with ArhI and 
healthy subjects. The difference between the two groups is statistically significant 
(U=544, P=0.039).
Abbreviation: ArhI, age-related hearing impairment.
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scores. SDS values were significantly negatively correlated 
with the BAK1/BCL2 ratio. This finding is consistent with the 
reduced speech understanding exhibited by ARHI patients;3 
however, the speech in noise test may be helpful to improving 
understanding of the relationship between BAK1/BCL2 ratios 
and speech understanding in people with ARHI.
Our findings are in agreement with previous studies and 
support the hypothesis that elevated BAK1 expression induces 
the apoptotic pathway in hair cells, initiating the molecular 
mechanism of impairment. Manipulation of the BAK1 gene 
pathway is a treatment target of apoptosis-related diseases.24 
Supplementation of mouse food, by increasing coenzyme 
Q10 and lipoic acid content, reduced Bak1 expression in the 
cochlea and prevented age-related HL.7
ARHI has profound economic and social health impacts, 
and the increasing elderly population makes ARHI an 
important issue for future generations. There is a long delay 
between the start of ARHI-related bodily changes and 
signs that are measurable using standard diagnostic tests.25 
Therefore, there is a pressing need for a suitable diagnostic 
biomarker for ARHI, and this is actively being sought by 
a number of research groups. Observation of a decline in 
the auditory brainstem gap from middle age in human and 
animal models was one interesting result in this area.23,26 
BAK1 has previously been identified as a predictive and 
prognostic biomarker in cancer therapy.27 The significantly 
elevated expression of BAK1 in peripheral blood samples 
from subjects with ARHI and the correlation of its expres-
sion with increased PTA and SRT values indicate that it 
may be a suitable and easy-to-use early detection diagnostic 
biomarker for this impairment. Further studies using a larger 
study population are required to confirm the present findings 
and establish their application in clinical practice.
Conclusion
In summary, we demonstrate an upregulation of BAK1 gene 
expression and the BAK1/BCL2 ratio in peripheral blood 
samples from Iranian ARHI subjects. Both BAK1 gene 
expression and the BAK1/BCL2 ratio were significantly cor-
related with the result of audiological tests routinely used for 
the diagnosis of presbycusis. Furthermore, the observation of 
significant changes in the expression of the apoptosis-related 
gene, BAK1, in peripheral blood samples suggests that it may 
be a useful biomarker for rapid diagnosis of ARHI.
Acknowledgments
We gratefully appreciate all the volunteers for participat-
ing in this scientific research. We thank the department and 
audiometry clinic of Rasoul Akram Hospital of Iran University 
of Medical Science for their kind cooperation during this 
research. We would like to acknowledge the Iran University 
of Medical Sciences for supporting this research.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Yang CH, Schrepfer T, Schacht J. Age-related hearing impairment and 
the triad of acquired hearing loss. Front Cell Neurosci. 2015;9:276.
 2. Ciorba A, Hatzopoulos S, Bianchini C, Aimoni C, Skarzynski H, 
Skarzynski PH. Genetics of presbycusis and presbystasis. Int J 
Immunopathol Pharmacol. 2015;28(1):29–35.
 3. Huang Q, Tang J. Age-related hearing loss or presbycusis. Eur Arch 
Otorhinolaryngol. 2010;267(8):1179–1191.
 4. Sha SH, Chen FQ, Schacht J. Activation of cell death pathways in the inner 
ear of the aging CBA/J mouse. Hear Res. 2009;254(1–2):92–99.
 5. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities 
that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47–59.
 6. Yang L, Zhang H, Han X, et al. Attenuation of hearing loss in DBA/2J 
mice by anti-apoptotic treatment. Hear Res. 2015;327:109–116.
 7. Someya S, Xu J, Kondo K, et al. Age-related hearing loss in C57BL/6J 
mice is mediated by Bak-dependent mitochondrial apoptosis. Proc Natl 
Acad Sci U S A. 2009;106(46):19432–19437.
 8. Tadros SF, D’Souza M, Zhu X, Frisina RD. Apoptosis-related genes 
change their expression with age and hearing loss in the mouse cochlea. 
Apoptosis. 2008;13(11):1303–1321.
 9. Van Eyken E, Van Laer L, Fransen E, et al. KCNQ4: a gene for age-
related hearing impairment? Hum Mutat. 2006;27(10):1007–1016.
 10. Van Laer L, Huyghe JR, Hannula S, et al. A genome-wide association 
study for age-related hearing impairment in the Saami. Eur J Hum 
Genet. 2010;18(6):685–693.
 11. Hajiabolhassan F, Lotfi Y, Azordegan F. Introducing and evaluating a 
Farsi – language version of the staggered spondaic word test in normal 
hearing subject. Audiol. 2006;15(1):39–46.
 12. Westphal D, Dewson G, Czabotar PE, Kluck RM. Molecular biology of 
Bax and Bak activation and action. Biochim Biophys Acta. 2011;1813(4): 
521–531.
 13. Iyer S, Bell F, Westphal D, et al. Bak apoptotic pores involve a flexible 
C-terminal region and juxtaposition of the C-terminal transmembrane 
domains. Cell Death Differ. 2015;22(10):1665–1675.
 14. Brooks C, Wei Q, Feng L, et al. Bak regulates mitochondrial morphology 
and pathology during apoptosis by interacting with mitofusins. Proc 
Natl Acad Sci U S A. 2007;104(28):11649–11654.
 15. Martin LJ, Liu Z, Pipino J, Chestnut B, Landek MA. Molecular regula-
tion of DNA damage-induced apoptosis in neurons of cerebral cortex. 
Cereb Cortex. 2009;19(6):1273–1293.
 16. Dong Y, Li M, Liu P, Song H, Zhao Y, Shi J. Genes involved in 
immunity and apoptosis are associated with human presbycusis based 
on microarray analysis. Acta Otolaryngol. 2014;134(6):601–608.
 17. van Delft MF, Huang DC. How the Bcl-2 family of proteins interact to 
regulate apoptosis. Cell Res. 2006;16(2):203–213.
 18. Cunningham LL, Matsui JI, Warchol ME, Rubel EW. Overexpression of 
Bcl-2 prevents neomycin-induced hair cell death and caspase-9 activation 
in the adult mouse utricle in vitro. J Neurobiol. 2004;60(1):89–100.
 19. Khodapasand E, Jafarzadeh N, Farrokhi F, Kamalidehghan B, 
Houshmand M. Is Bax/Bcl-2 ratio considered as a prognostic marker with 
age and tumor location in colorectal cancer? Iran Biomed J. 2015;19(2): 
69–75.
 20. Golestani Eimani B, Sanati MH, Houshmand M, Ataei M, Akbarian F, 
Shakhssalim N. Expression and prognostic significance of bcl-2 and 
bax in the progression and clinical outcome of transitional bladder cell 
carcinoma. Cell J. 2014;15(4):356–363.
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
22
5.
18
7.
18
0 
on
 1
6-
O
ct
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Interventions in Aging
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-interventions-in-aging-journal
Clinical Interventions in Aging is an international, peer-reviewed journal 
focusing on evidence-based reports on the value or lack thereof of treatments 
intended to prevent or delay the onset of maladaptive correlates of aging 
in human beings. This journal is indexed on PubMed Central, MedLine, 
CAS, Scopus and the Elsevier Bibliographic databases. The manuscript 
management system is completely online and includes a very quick and fair 
peer-review system, which is all easy to use. Visit http://www.dovepress.
com/testimonials.php to read real quotes from published authors.
Clinical Interventions in Aging 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
1008
Falah et al
 21. Jacobson M, Kim S, Romney J, Zhu X, Frisina RD. Contralateral 
suppression of distortion-product otoacoustic emissions declines with 
age: a comparison of findings in CBA mice with human listeners. 
Laryngoscope. 2003;113(10):1707–1713.
 22. Kim S, Frisina DR, Frisina RD. Effects of age on contralateral sup-
pression of distortion product otoacoustic emissions in human listeners 
with normal hearing. Audiol Neurootol. 2002;7(6):348–357.
 23. Zhu X, Vasilyeva ON, Kim S, et al. Auditory efferent feedback system 
deficits precede age-related hearing loss: contralateral suppression 
of otoacoustic emissions in mice. J Comp Neurol. 2007;503(5): 
593–604.
 24. Karasawa S, Azuma M, Kasama T, et al. Vitamin K2 covalently binds 
to Bak and induces Bak-mediated apoptosis. Mol Pharmacol. 2013; 
83(3):613–620.
 25. Carson AJ. “What brings you here today?” The role of self-assessment 
in help-seeking for age-related hearing loss. J Aging Stud. 2005;19(2): 
185–200.
 26. Williamson TT, Zhu X, Walton JP, Frisina RD. Auditory brainstem gap 
responses start to decline in mice in middle age: a novel physiological 
biomarker for age-related hearing loss. Cell Tissue Res. 2015;361(1): 
359–369.
 27. Kubo T, Kawano Y, Himuro N, et al. BAK is a predictive and prognostic 
biomarker for the therapeutic effect of docetaxel treatment in patients 
with advanced gastric cancer. Gastric Cancer. 2016;19(3):827–838.
 
Cl
in
ica
l I
nt
er
ve
nt
io
ns
 in
 A
gi
ng
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
22
5.
18
7.
18
0 
on
 1
6-
O
ct
-2
01
9
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
